Health Canada Approves Zoetis’ Portela for Feline OA Pain
PARSIPPANY, N.J., December 5, 2025 — Zoetis Inc. announced that Health Canada has approved Portela™ (relfovetmab injection) for the...
Veterinary Biologics
Advertisement
Junevity Secures $20M to Advance siRNA Cell-Reprogramming Platform
SAN FRANCISCO, December 3, 2025 — Junevity today announced the expansion of its seed funding round to $20 million...
Zoetis Showcases R&D Strength and Growth in Animal Health
PARSIPPANY, N.J., December 3, 2025 — Zoetis has highlighted its R&D leadership, expanding innovation strategy, and long-term growth outlook...
Gallant Advances First Ready-to-Use Veterinary Stem Cell Therapy
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
Advertisement
